Key facts
- Notable investors include LEA Partners, First Momentum Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Atlas Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Atlas Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Atlas Bio
Developer of an animal testing simulation designed to reduce the failure rate of clinical trials. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Basel, Switzerland
- Founded
- 2024
- Website
- atlas.bio/
- Ownership
- Privately Held (backing)
Atlas Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atlas Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atlas Bio in its N-PORT filings yet. We sweep new filings monthly.